secwatch.observer — SEC 8-K summary
======================================

Issuer:     Advanced Biomed Inc. (ADVB)
CIK:        0001941029
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001213900-26-036424
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Advanced Biomed CTO and director Steven I-Fang Cheng resigns; CFO Mingze Yin appointed to board
--------------------------------------------------------------------------------

- Steven I-Fang Cheng resigned as director and CTO effective March 25, 2026; no disagreement with company.
- Mingze Yin, CFO, appointed as director effective March 25, 2026.
- No family relationships or transactions requiring disclosure for Mr. Yin.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1941029/000121390026036424/0001213900-26-036424-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1941029/000121390026036424/ea028408401-8k_advancedbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-036424

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer